Effects of Miglitol on Daily Plasma Glucose in type2 Diabetes Treated With Insulin

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

In this study, the effect of miglitol on daily plasma glucose will be evaluated in type 2 diabetic patients treated with insulin.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sanwa Kagaku Kenkyusho Co., Ltd.
• Treatments: Miglitol

Criteria

Inclusion Criteria:

• type2 diabetes

• postprandial plasma glucose levels ≧180mg/dl

Exclusion Criteria:

• type1 diabetes

• AST(GOT) or ALT(GPT) ≧100IU/l

• creatinine ≧2.0mg/dl